28 devices · GMDN 57243
Glucagon IVD antibody devices are laboratory reagents designed to detect the hormone glucagon in clinical samples. Clinically, they help diagnose conditions like glucagonoma tumors, insulinomas, or other metabolic disorders by identifying abnormal glucagon levels in blood, serum, or urine.
These devices are typically regulated as in vitro diagnostics (IVDs) and may require compliance with standards like ISO 13485 or FDA 21 CFR Part 820. They are usually supplied as kits or reagents for use in immunoassays, often classified based on their intended use and risk level, though classification varies by jurisdiction.
This category summary is AI-generated from the GMDN nomenclature and has not been verified by a human reviewer.